A companion study to PMID 18197389, further demonstrating that Selank reverses neurodevelopmental deficits from prenatal hypoxia. Confirms that Selank (300 μg/kg) significantly improves sensory attention (2–3x), learning capacity (1.5x), and normalizes serotonergic/noradrenergic brain balance in adult rats exposed to hypoxia during gestation—supporting developmental neuroprotection.
Semenova, T P; Kozlovskaia, M M; Zuĭkov, A V; Kozlovskiĭ, I I; Zakharova, N M; Andreeva, L A